Global Markets
thumbnail
Global Markets
The ‘fishy’ business of bioprocessing exposed at BPI EuropeThe ‘fishy’ business of bioprocessing exposed at BPI Europe
Lab-grown fish offers a sustainable alternative to current seafood production methods but suffers many of the same manufacturing-based pain points as the biopharma industry, says cultivated fish firm BLUU.
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.